All the Active Ingredient Drugs
Antiretrovirals. Bictegravir 50 mg, Emtricitabine 200 mg, Tenofovir Alafenamide 25 mg. F.C. TABS.: 30. 1 tab×1/d with/without
food. If the patient misses a dose
within 18 hours of the time it is
usually taken, the patient should take
the drug as soon as possible and
resume the normal dosing schedule.
If a patient misses a dose by more
than 18 hours, the patient should not
take the missed dose and simply
resume the usual dosing schedule.
If the patient vomits within 1 hour of
taking the drug another tablet should
be taken. If a patient vomits more
than 1 hour after taking the drug they
do not need to take another dose of
the drug until the next regularly
scheduled dose.
Treatment of adults infected with human
immunodeficiency virus-1 (HIV-1) without
present or past evidence of viral resistance
to the integrase inhibitor class,
emtricitabine or tenofovir.
C/I: Hypersens.
Co-admin. with rifampicin and St John’s
wort (Hypericum perforatum).
Anti HIV, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors. Emtricitabine 200 mg, Tenofovir Alafenamide 10 mg, 25 mg. F.C. TABS.:30. Dosage must be ajust. individ.
Indicated in comb. with other antiretrovir. agents for the tmt. of adult. and adolesc. (aged 12 yrs. and older with bdy. wt. at least 35 kg) infect. with human immunodeficiency virus type 1 (HIV-1).
C/I: Hypersens.
Nuclease Reverse Transcriptase Inhibitor. Tenofovir Disoproxil 245 mg, Emtricitabine 200 mg. FC tab.:30/90 See lit..
Tmt of HIV-1 infec.:in comb. with other anti-retroviral med. prod. for the tmt of HIV-1 infec. adlt. over 18 yrs.
Pre-expos. Proph. (PrEP): in comb. with safer sex practices for pre-expos. Proph. to reduce the risk of sex. Acquir. HIV-1 infec. in adlt at high risk.
C/I: see lit.
Antivirals for Treatment of HIV Infections. Emtricitabine 200 mg, Tenofovir Disoproxil (as fumarate) 245 mg. TABS.: 30. 1 tab×1/d with food. in case of missed a dose of the drug by more than 12 hrs. close to the time of next dose, missed dose should not be taken, simply resume the usual dosing schedule. In case of vomit. within 1 h. of taking the drug, another tab. should be taken. In case of vomit. more than 1 h. after taking this drug, re-adminst. is not necessar. See lit.
Indic. In comb. with other anti-retrov. meds. products for the tmt. of HIV-1 infect. adult. over 18 yrs. of age. In comb. with safer sex practices for preexposure prophylax. to reduce the risk of sexual. acquir. HIV-1 infec. in adult. at high risk.
C/I: Hypersens.
Antiretrovirals. Emtricitabine 200 mg, Elvitegravir 150 mg, Cobicistat 150 mg. FILM COAT. TABS.:30.
Adult., paed. 6 yrs. and older, wt. at least 25 kg: 1 tab. ×1/d with food. If the pt. misses a dose within 18 hrs. of the time it is usual. taken, the pt. should take the drug with food as soon as possible and resume the normal dosing schedule. If a pt. misses a dose by more than 18 hrs., the pt. should not take the missed dose and simply resume the usual dosing schedule. If the pt. vomit. within 1 h of taking the drug another tab. should be taken.
Tmt. of adults & adolesc. (aged 12 yrs.& older with bdy. wt. at least 35 kg) and In child. aged 6 yrs. & older with bdy wt at least 25 kg for whom alternative regimens are unsuitable due to toxicities infect. with HIV 1 without any known mutations assoc. with resist. to the integrase inhib. class, emtricitabine or tenofovir.
C/I: Hypersens. Co-admin. with: Alfuzosin, amiodarone, quinidine, dihydroergotamine, ergometrine, ergotamine, cisapride, lovastatin, simvastatin, lomitapide, pimozide, lurasidone, sildenafil for tmt. of pulmon. arter. Hypertens., midazolam, triazolam, carbamazepine, phenobarbital, phenytoin, rifampicin, St. John’s wort (Hyperic. perfora.), dabigatran.
Antivirals for Treatment of HIV Infections. Emtricitabine 200 mg, Rilpivirine 25 mg, Tenofovir Alafenamide 25 mg. FC Tab. 200/25/25 mg X 30
1 dly. with food
Tmt. of adlts. and adolesc. (aged 12 years and older with
weight of at least 35 kg) infect. with human immunodefic. virus-1 (HIV-1) without known mutat. assoc. with resist. to the non-nucleoside reverse transcriptase inhib. (NNRTI) class, tenofovir or emtricitabine and with viral load ≤ 100,000 HIV-1 RNA copies/mL
C/I: Hypersens. Should not be co-admin. with drugs that can result in signific. decr. in rilpivirine plasma concentr. (due to cytochr. P450 [CYP]3A enzyme induct. or gastric pH incr.), which may result in loss of ther. effect of this drug includ.:
• carbamazepine, oxcarbazepine, phenobarbital, phenytoin
• rifabutin, rifampicin, rifapentine
• omeprazole, esomeprazole, dexlansoprazole, lansoprazole, pantoprazole, rabeprazole
• dexamethasone (oral and parenteral doses), except as a sgle. dose tmt.
• St. John’s wort (Hypericum perforatum)
